SCHEMBL30658218

CC[C@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](N)CO)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(C)C

nearest known ligand 0.74

Predicted protein targets (top 5)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	19/20	0.74

▸	CCKBR	P32239	1/20	0.72

▸	ECE1	P42892	1/20	0.70

▸	MUS81	Q96NY9	1/20	0.70

▸	KEAP1	Q14145	1/20	0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30495713	0.96	GLP1R (0.74)	GLP1RCCKBRECE1MUS81KEAP1
SCHEMBL30658231	0.94	GLP1R (0.70)	GLP1RCCKBRECE1MUS81KEAP1
SCHEMBL29352259	0.93	GLP1R (0.76)	GLP1RCCKBRECE1MUS81
Oxyntomodulin SCHEMBL29449850	0.93	GLP1R (0.76)	GLP1RCCKBRECE1MUS81
SCHEMBL31280543	0.93	GLP1R (0.75)	GLP1RCCKBRECE1MUS81
SCHEMBL30657454	0.93	GLP1R (0.75)	GLP1RCCKBR
SCHEMBL29540315	0.93	GLP1R (0.76)	GLP1RCCKBR
SCHEMBL29608077	0.93	GLP1R (0.76)	GLP1RCCKBR
SCHEMBL31140017	0.92	GLP1R (0.77)	GLP1RCCKBR
SCHEMBL31099253	0.92	GLP1R (0.76)	GLP1RCCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-11753627-B2	Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US)	2023-09-12	—	—	US	disclosed